Evidence map›Paper›PMID 31813850›Full record

ReviewThe Lancet. Neurology2020

The global burden of neurological disorders: translating evidence into policy.

Valery L Feigin, Theo Vos, Emma Nichols, Mayowa O Owolabi, William M Carroll, Martin Dichgans, Günther Deuschl, Priya Parmar, Michael Brainin, Christopher Murray

Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in The Lancet. Neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07731191 (Development of Digital Solutions for the Prediction of the Biological Mechanisms of Alzheimer's Disease Through the Analysis of Risk Factors), which is not on this map. Cited by 612 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
612citing papers in PubMed, 9 pooled it
22.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07731191 narecruitingnot on this mapstarted 2026, after this paper: background citation

Development of Digital Solutions for the Prediction of the Biological Mechanisms of Alzheimer's Disease Through the Analysis of Risk Factors (PrevAI)

TypeinterventionalSponsorIRCCS Centro San Giovanni di Dio FatebenefratelliRan2026 to 2026Enrolled240ConditionsMild Cognitive Impairment (MCI), Subjective Cognitive Decline (SCD)ArmsDigital solution for the prediction of the biological mechanisms of Alzheimer's disease through the analysis of risk factors
3 · Its place in the literature

Who cites it

612 citing papers in PubMed, 9 syntheses or guidelines pooled it, 1,115 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Facilitators and Barriers of the Use of Prognostic Models for Clinical Decision Making in Acute Neurologic Care: A Systematic Review.Medical decision making : an international journal of the Society for Medical Decision Making · 2025
    Pooled it
  10. Trial
  11. Trial
  12. Long-term trends in selected neurological disorders in Italy (1990-2023): analysis of the global burden of disease (GBD) 2023 data.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article

552 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 8 institutions in 6 countries.

Valery L FeiginNational Institute for Stroke and Applied Neurosciences, Faculty of Health and Environmental Sciences, Auckland University of Technology, Auckland, New Zealand. Electronic address: valery.feigin@aut.ac.nz.
Theo VosInstitute for Health Metrics Evaluation, University of Washington, Seattle, WA, USA.
Emma NicholsInstitute for Health Metrics Evaluation, University of Washington, Seattle, WA, USA.
Mayowa O OwolabiCenter for Genomic and Precision Medicine, College of Medicine, University of Ibadan, Ibadan, Nigeria.
William M CarrollSir Charles Gairdner Hospital, Perth, WA, Australia.
Martin DichgansInstitute for Stroke and Dementia Research, University Hospital, and Munich Cluster of Systems Neurology, Ludwig-Maximilians University, Munich, Germany.
Günther DeuschlDepartment of Neurology, University Centre Schleswig-Holstein, Christian-Albrechts University, Kiel, Germany.
Priya ParmarNational Institute for Stroke and Applied Neurosciences, Faculty of Health and Environmental Sciences, Auckland University of Technology, Auckland, New Zealand.
Michael BraininDepartment of Neurosciences and Preventive Medicine, Danube University Krems, Krems, Austria.
Christopher MurrayInstitute for Health Metrics Evaluation, University of Washington, Seattle, WA, USA.
Auckland University of Technology · NZUniversity of Washington · USInstitute for Health Metrics and Evaluation · USKiel University · DELudwig-Maximilians-Universität München · DESir Charles Gairdner Hospital · AUUniversität für Weiterbildung Krems · ATUniversity of Ibadan · NG

Funding

EPIDEMIOLOGY AND BIOSTATISTICS OF AGINGT32AG000247 · NIA · JOHNS HOPKINS UNIVERSITY · PI Karen J. Bandeen-Roche · 1996 to 2026
$13.2M
NIA NIH HHS T32 AG000247
6 · The paper itself

Abstract

Neurological disorders are the leading cause of disability and the second leading cause of death worldwide. In the past 30 years, the absolute numbers of deaths and people with disabilities owing to neurological diseases have risen substantially, particularly in low-income and middle-income countries, and further increases are expected globally as a result of population growth and ageing. This rise in absolute numbers of people affected suggests that advances in prevention and management of major neurological disorders are not sufficiently effective to counter global demographic changes. Urgent measures to reduce this burden are therefore needed. Because resources for health care and research are already overstretched, priorities need to be set to guide policy makers, governments, and funding organisations to develop and implement action plans for prevention, health care, and research to tackle the growing challenge of neurological disorders.

Indexed as

FemaleGlobal Burden of DiseaseGlobal HealthHumansLife ExpectancyMaleNervous System DiseasesQuality-Adjusted Life YearsQuality of LifeSocioeconomic Factors

Identifiers

PMID31813850
PMCPMC9945815
OpenAlexW2991851654

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.